FI970833A0 - Dihydro-2,3-bentsodiatsepiinijohdannaiset - Google Patents

Dihydro-2,3-bentsodiatsepiinijohdannaiset

Info

Publication number
FI970833A0
FI970833A0 FI970833A FI970833A FI970833A0 FI 970833 A0 FI970833 A0 FI 970833A0 FI 970833 A FI970833 A FI 970833A FI 970833 A FI970833 A FI 970833A FI 970833 A0 FI970833 A0 FI 970833A0
Authority
FI
Finland
Prior art keywords
phenyl
alkyl
dihydro
benzodiazepine derivatives
amino
Prior art date
Application number
FI970833A
Other languages
English (en)
Swedish (sv)
Other versions
FI970833A (fi
FI113049B (fi
Inventor
Benjamin Alan Anderson
Marvin Martin Hansen
Nancy Kay Harn
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI970833A0 publication Critical patent/FI970833A0/fi
Publication of FI970833A publication Critical patent/FI970833A/fi
Application granted granted Critical
Publication of FI113049B publication Critical patent/FI113049B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
FI970833A 1994-08-31 1997-02-27 (R)-7-(aryylisubstituoitu)-8,9-dihydro-8-alkyyli-5-(4-aminofenyyli)-7-H-1,3-dioksolo[4,5-h] [2,3]bentsodiatsepiini- tai (R)-7-(aryylisubstituoitu)-8,9-dihydro-8-alkyyli-5-(4-nitrofenyyli)-7-H-1,3-dioksolo [4,5-h] [2,3] -bentsodiatsepiiniyhdiste FI113049B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US29864594A 1994-08-31 1994-08-31
US29864594 1994-08-31
US41302995A 1995-03-28 1995-03-28
US41302995 1995-03-28
US9510945 1995-08-30
PCT/US1995/010945 WO1996006606A1 (en) 1994-08-31 1995-08-30 Dihydro-2,3-benzodiazepine derivatives

Publications (3)

Publication Number Publication Date
FI970833A0 true FI970833A0 (fi) 1997-02-27
FI970833A FI970833A (fi) 1997-02-27
FI113049B FI113049B (fi) 2004-02-27

Family

ID=26970798

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970833A FI113049B (fi) 1994-08-31 1997-02-27 (R)-7-(aryylisubstituoitu)-8,9-dihydro-8-alkyyli-5-(4-aminofenyyli)-7-H-1,3-dioksolo[4,5-h] [2,3]bentsodiatsepiini- tai (R)-7-(aryylisubstituoitu)-8,9-dihydro-8-alkyyli-5-(4-nitrofenyyli)-7-H-1,3-dioksolo [4,5-h] [2,3] -bentsodiatsepiiniyhdiste

Country Status (13)

Country Link
US (1) US5795886A (fi)
EP (3) EP0771198B1 (fi)
JP (1) JP4131987B2 (fi)
AT (2) ATE212994T1 (fi)
CA (1) CA2198751C (fi)
DE (2) DE69525342T2 (fi)
DK (2) DK0771198T3 (fi)
ES (2) ES2170804T3 (fi)
FI (1) FI113049B (fi)
HK (1) HK1013794A1 (fi)
NZ (1) NZ292417A (fi)
PT (2) PT1157992E (fi)
WO (1) WO1996006606A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA972746B (en) * 1996-04-04 1998-10-09 Egyt Gyogyszervegyeszeti Gyar Novel 2,3-benzodiazepine derivatives
HUP9701325A1 (hu) * 1997-07-31 2000-08-28 Gyógyszerkutató Intézet Kft. Új 2,3-benzodiazepin-származékok
HU9803014D0 (en) * 1998-12-23 1999-02-01 Egyt Gyogyszervegyeszeti Gyar Novel phtalazine derivatives, process for their production and pharmaceutical compositions containing the same
HU227128B1 (en) * 1999-07-07 2010-07-28 Egyt Gyogyszervegyeszeti Gyar New 2,3-benzodiazepine derivatives
US6649607B2 (en) * 2001-05-18 2003-11-18 Vela Pharmaceuticals, Inc. Compositions and methods for treating or preventing convulsions or seizures
US6858605B2 (en) * 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
TW200902024A (en) * 2007-04-02 2009-01-16 Teva Pharma Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
HU206719B (en) * 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
HU219777B (hu) * 1993-07-02 2001-07-30 Gyógyszerkutató Intézet Kft. Optikailag aktív 1-(4-nitro-fenil)-4-metil-7,8-metiléndioxi-3,4-dihidro-5H-2,3-benzodiazepin és eljárás előállítására

Also Published As

Publication number Publication date
HK1013794A1 (en) 1999-09-10
NZ292417A (en) 1998-09-24
EP1157992A1 (en) 2001-11-28
DE69525342D1 (de) 2002-03-21
CA2198751C (en) 2006-07-11
DE69534407D1 (de) 2005-09-29
EP0771198B1 (en) 2002-02-06
EP1157992B1 (en) 2005-08-24
JP4131987B2 (ja) 2008-08-13
PT771198E (pt) 2002-06-28
FI970833A (fi) 1997-02-27
ES2170804T3 (es) 2002-08-16
DK0771198T3 (da) 2002-04-22
DE69534407T2 (de) 2006-03-16
JPH10505066A (ja) 1998-05-19
PT1157992E (pt) 2005-10-31
DK1157992T3 (da) 2005-10-24
ATE212994T1 (de) 2002-02-15
WO1996006606A1 (en) 1996-03-07
EP0771198A4 (fi) 1997-05-28
EP1593683A2 (en) 2005-11-09
DE69525342T2 (de) 2002-11-07
EP1593683A3 (en) 2006-10-25
AU689639B2 (en) 1998-04-02
EP0771198A1 (en) 1997-05-07
ES2244524T3 (es) 2005-12-16
AU3418695A (en) 1996-03-22
ATE302779T1 (de) 2005-09-15
FI113049B (fi) 2004-02-27
CA2198751A1 (en) 1996-03-07
US5795886A (en) 1998-08-18

Similar Documents

Publication Publication Date Title
DE69425162T2 (de) 4,5-diaryloxazol-derivate
MX9800577A (es) Derivados de 4,5-diaril oxazol.
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
WO1998028282A3 (en) OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
DK0598359T3 (da) Hypoglykæmiske dihydrochalconderivater
NO307299B1 (no) Mellomprodukt for fremstilling av terapeutisk aktive forbindelser
ATE203515T1 (de) Meta-substituierte phenylsulphonamidderivate
WO2001062705A8 (en) Aminoalcohol derivatives
PE46699A1 (es) Compuesto derivado de indol
ES2126075T3 (es) Derivados biciclicos nitrogenados como inhibidores de la propil-endopeptidasa.
DK1157992T3 (da) Dihydro-2,3-benzodiazepinederivativer
MY128323A (en) Thiazole derivatives for inhibition of cytokine production and of cell adhesion
TR200001239T2 (tr) Tiyazolidinediyon türevlerini hazırlama prosesi.
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
DE69914880D1 (de) Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate
DE60323862D1 (de) 1,2,4-triazolderivat, verfahren zu dessen herstellung, und dieses enthaltende pharmazeutische zusammensetzung
ATE228359T1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten
WO1996025933A3 (en) Use of vinyl carboxylic acid compounds for the treatment or prevention of transient ischaemic attacks